Famed ESPN broadcaster Dick Vitale is facing another battle with cancer. Vitale said Monday that biopsy results had confirmed ...

The BRAF-mutated NSCLC market is poised for growth due to an increasing incidence rate across 7MM. Currently, only one approved therapy, the Tafinlar and Mekinist combo, targets this mutation.

Lung cancer is the deadliest cancer—but early screening can save lives. A survivor’s story and expert insight show why ...

University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...

If approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...

Famed ESPN broadcaster Dick Vitale is facing another battle with cancer. Vitale said Monday that biopsy results had confirmed ...

Whether it was breaking news, high-profile stories, features, or Friday Night football, if it was on the air, odds are that ...

Oncologists are leveraging TikTok to provide evidence-based cancer education, breaking down complex clinical topics for patients and peers.

Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...

This antibody-drug conjugate targets a specific protein associated with poor prognosis in patients whose disease progressed after platinum-based chemotherapy.